Onesource Specialty Pharma

Onesource Specialty Pharma Piotroski F-Score

The Piotroski F-Score of Onesource Specialty Pharma (ONESOURCE.NS) as of Nov 17, 2026 is 1. In the previous year, Piotroski F-Score was 5.00 — a change of -80.00% (lower).

Piotroski F-Score

1

YoY

-80.00%

Last updated:

Piotroski F-Score of Onesource Specialty Pharma is 2026 1 . Piotroski F-Score of Onesource Specialty Pharma was 2025 5.00 . It decreases by -80.00% lower compared to the previous year.

The Onesource Specialty Pharma Piotroski F-Score history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Piotroski F-Score
Date
Piotroski F-Score
Jan 1, 2024
5.00 INR
Jan 1, 2025
5.00 INR
Jan 1, 2026
1.00 INR
The Onesource Specialty Pharma Piotroski F-Score history
YEARPiotroski F-ScoreYoY
1-80.00%
50.00%
5—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Onesource Specialty Pharma Stock analysis

What does Onesource Specialty Pharma do? Onesource Specialty Pharma Ltd operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO) within the Life Sciences Tools & Services industry. Based in Bangalore, Karnataka, the India-based company provides vertically integrated biopharma services, focusing on the development and manufacture of complex biologics, biosimilars, and vaccines. Its core offerings include prefilled syringes with or without safety devices, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors. The firm supports the development of complex biologics such as microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and ribonucleic acid (RNA) products. The company generates revenue by catering to a variety of capsule shapes and sizes through its integrated services. These services encompass formulations ranging from traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and su. By providing comprehensive biologics solutions, the firm serves clients requiring advanced manufacturing capabilities for diverse pharmaceutical delivery systems and therapeutic modalities. Onesource Specialty Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Onesource Specialty Pharma stock

Piotroski F-Score of Onesource Specialty Pharma is 1 in 2026.

On Eulerpool you can find the complete historical development of Piotroski F-Score Onesource Specialty Pharma since 2006 – with annual values, charts, and detailed analysis.

The Piotroski F-Score rates a company from 0-9 based on profitability, leverage, liquidity, and operating efficiency. Scores of 8-9 indicate strong fundamentals.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Onesource Specialty Pharma

All Key Metrics — Onesource Specialty Pharma